Overview of Advancement in Biosensing Technology, Including its Applications in Healthcare
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Clinical analysis necessitates using rapid and dependable diagnostic methodologies and approaches. Biomarkers may be an appropriate choice to fulfill this objective, as they are designed uncomplicated in use, specialized for the desired metabolite, susceptible to ongoing analysis and providing excellent outcomes, relatively affordable in the budget, and easily accessible. Biosensing devices are increasingly extensively utilized for treatment, and therefore a variety of applications such as prudence treatment and illness advancement surveillance, environment sensing, product standard, medicine development, toxicology, and scientific engineering. Biosensors can be developed using a wide variety of ways. Its combination with high-affinity macromolecules enables them to monitor a diverse variety of solutes in a specific as well as responsive manner. Enhanced sensing innovation leads to the detection of infection as well as the monitoring of people's reactions after treatment. Sensing tools are essential for a range of low and better implantable implants. Nanosensors offer a lot of prospects because they are simple, flexible, yet economical to develop. This article presents a detailed overview of breakthroughs in the subject and demonstrations of the variety of biosensors and the extension of nanoscience and nanotechnology methodologies that are applicable today.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Current pharmaceutical biotechnology - 24(2023), 3 vom: 27., Seite 411-426 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mishra, Sakshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alzheimer’s disease |
|---|
| Anmerkungen: |
Date Completed 10.03.2023 Date Revised 10.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389201023666220610163343 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342242628 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342242628 | ||
| 003 | DE-627 | ||
| 005 | 20231226013644.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389201023666220610163343 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342242628 | ||
| 035 | |a (NLM)35702798 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mishra, Sakshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Overview of Advancement in Biosensing Technology, Including its Applications in Healthcare |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.03.2023 | ||
| 500 | |a Date Revised 10.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Clinical analysis necessitates using rapid and dependable diagnostic methodologies and approaches. Biomarkers may be an appropriate choice to fulfill this objective, as they are designed uncomplicated in use, specialized for the desired metabolite, susceptible to ongoing analysis and providing excellent outcomes, relatively affordable in the budget, and easily accessible. Biosensing devices are increasingly extensively utilized for treatment, and therefore a variety of applications such as prudence treatment and illness advancement surveillance, environment sensing, product standard, medicine development, toxicology, and scientific engineering. Biosensors can be developed using a wide variety of ways. Its combination with high-affinity macromolecules enables them to monitor a diverse variety of solutes in a specific as well as responsive manner. Enhanced sensing innovation leads to the detection of infection as well as the monitoring of people's reactions after treatment. Sensing tools are essential for a range of low and better implantable implants. Nanosensors offer a lot of prospects because they are simple, flexible, yet economical to develop. This article presents a detailed overview of breakthroughs in the subject and demonstrations of the variety of biosensors and the extension of nanoscience and nanotechnology methodologies that are applicable today | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Alzheimer’s disease | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a biosensors | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a electrochemical biosensors | |
| 650 | 4 | |a immunological biosensors | |
| 650 | 4 | |a optical biosensors | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Deshmukh, Rohitas |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d 2000 |g 24(2023), 3 vom: 27., Seite 411-426 |w (DE-627)NLM11369072X |x 1873-4316 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:3 |g day:27 |g pages:411-426 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389201023666220610163343 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 3 |b 27 |h 411-426 | ||